Fusion Pharm (Fusion Pharm) EBIT : $ Mil (TTM As of . 20)

View and export this data going back to . Start your Free Trial

What is Fusion Pharm EBIT?

Fusion Pharm's earnings before interest and taxes (EBIT) for the three months ended in . 20 was $0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Fusion Pharm EBIT Historical Data

The historical data trend for Fusion Pharm's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fusion Pharm EBIT Chart

Fusion Pharm Annual Data

Trend

EBIT

Fusion Pharm Quarterly Data

EBIT

Competitive Comparison of Fusion Pharm's EBIT

For the Pharmaceutical Retailers subindustry, Fusion Pharm's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fusion Pharm's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fusion Pharm's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Fusion Pharm's EV-to-EBIT falls into.

Fusion Pharm EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was $ Mil.

Fusion Pharm (OTCPK:FSPM) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Fusion Pharm's annualized ROC % for the quarter that ended in . 20 is calculated as:

	ROC % (Q: . 20 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: . 20 )	+	Invested Capital (Q: . 20 ))	/ count )
=	* ( 1 - % )	/	( (	+	)	/ )
=		/
=	%

where

Invested Capital

(Q: . 20 )

Total Assets

Accounts Payable & Accrued Expense

Excess Cash

Total Assets

Accounts Payable & Accrued Expense

( Cash, Cash Equivalents, Marketable Securities

max(0, Total Current Liabilities

Total Current Assets

Cash, Cash Equivalents, Marketable Securities

))

(

max(0,

))

Invested Capital

(Q: . 20 )

Total Assets

Accounts Payable & Accrued Expense

Excess Cash

Total Assets

Accounts Payable & Accrued Expense

( Cash, Cash Equivalents, Marketable Securities

max(0, Total Current Liabilities

Total Current Assets

Cash, Cash Equivalents, Marketable Securities

))

(

max(0,

))

Note: The Operating Income data used here is four times the quarterly (. 20) data.

2. Joel Greenblatt's definition of Return on Capital:

Fusion Pharm's annualized ROC (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

	ROC (Joel Greenblatt) %		(Q: . 20 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: . 20		Q: . 20
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=		/	( ( ( + max(, 0))	+	( + max(, 0)) )	/	)
=		/	( (	+	)	/	)
=		/
=	%

where Working Capital is:

	Working Capital		(Q: . 20 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(	+		+	)	-	(	+		+	)
=

	Working Capital		(Q: . 20 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(	+		+	)	-	(	+		+	)
=

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (. 20) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Fusion Pharm's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: . 20 )
	=		/	0.000
	=	%

Fusion Pharm EBIT Related Terms

Thank you for viewing the detailed overview of Fusion Pharm's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Fusion Pharm (Fusion Pharm) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fusion Pharm Inc (OTCPK:FSPM) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

5850 East 58th Avenue, Unit F, Commerce City, CO, USA, 80022

Website

http://www.fusionpharminc.com

Fusion Pharm Inc is engaged in commercializing its patent pending PharmPods line of hydroponic cultivation systems. Its PharmPods are used for agricultural cultivation by urban farming companies and other specialty growers. Pharmpods are constructed of standard ISO steel shipping containers that are repurposed for use in indoor plant cultivation.

Fusion Pharm (Fusion Pharm) Headlines

No Headlines